Title:
Intranasal curcumin regulates chronic asthma in mice by modulating NF-ĸB activation and MAPK signaling

dc.contributor.authorPreeti S. Chauhan
dc.contributor.authorD.K. Singh
dc.contributor.authorD. Dash
dc.contributor.authorRashmi Singh
dc.date.accessioned2026-02-07T08:44:24Z
dc.date.issued2018
dc.description.abstractBackground: Curcumin, a natural product found in the plant Curcuma longa, has been reported to have diverse range of molecular targets that influence numerous biochemical and molecular cascades including anti-inflammatory and antioxidant properties. Purpose: The aim of the study was to investigate the therapeutic potential of intranasal curcumin on ovalbumin (OVA)-induced chronic asthma and to elucidate underlying molecular mechanisms. Study design/method: Mice were sensitized and exposed to 2% OVA aerosol for 2 times in a week for five consecutive weeks to study effect of intranasal curcumin on various MAPK pathway enzymes involved in chronic asthma and its effect on the activation of nuclear factor kB (NF-kB). Results: Curcumin treatment decreased the ROS level in BALF and nitrite level in blood serum of chronic asthmatic mice. Curcumin treatment had significantly decreased the phosphorylation of JNK, ERK1/2, and p38 and COX-2 expression thereby nuclear factor κB (NF-κB) activation and expression in lung tissues. Conclusion: These results suggest that intranasal curcumin protects against asthma via action on mitogen-activated protein kinase (MAPK)/NF-κB signaling pathways. © 2018
dc.identifier.doi10.1016/j.phymed.2018.06.022
dc.identifier.issn9447113
dc.identifier.urihttps://doi.org/10.1016/j.phymed.2018.06.022
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/31640
dc.publisherElsevier GmbH
dc.subjectCurcumin
dc.subjectMAPK
dc.subjectNuclear factor κB and reactive oxygen species
dc.subjectOvalbumin
dc.titleIntranasal curcumin regulates chronic asthma in mice by modulating NF-ĸB activation and MAPK signaling
dc.typePublication
dspace.entity.typeArticle

Files

Collections